Reported Nov 4, 2026 · Ongoing

Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Tablets 40 mg/10 mg/12.5mg, packaged as a) 30-count bottle,…

Macleods Pharma USA, Inc.

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: MACLEODS PHARMA USA, INC · 103 College Rd E Fl 2 · Princeton, NJ · 08540-6611

Is this the product you have?

  • Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Tablets 40 mg/10 mg/12.5mg, packaged as a) 30-count bottle, NDC 33342-246-07; b) 90-count bottle, NDC 33342-246-10; Rx Only
  • Manufactured forMacleods Pharma USA, Inc. Princeton, NJ 08540
  • Manufactured byMacleods Pharmaceuticals Ltd, Daman, 396210, India
Lot codes and dates
    • Lot #: a) 12251163A
    • Exp 05-31-2027
    • b) 12251163B
    • Exp 05-31-2027
Amount recalled
3528 30-count and 216 90-count bottles

Where it was sold

  • Nationwide

Why it was recalled

Failed Dissolution Specifications.

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Macleods Pharma USA, Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (Enforcement Report)

Read the FDA (weekly enforcement report) notice

Data as of Nov 4, 12:27 AM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.